Comparison of the effect of topiramate versus gabapentin on neuropathic pain in patients with polyneuropathy
A randomized clinical trial
Keywords:
Neuralgia, Polyneuropathies, Gabapentin, TopiramateAbstract
Background: Neuropathic pain is one of the most common complaints of neurologic clinics. Neuropathic pain is common and important and has inappropriate complications, and despite their importance, there is no effective treatment for them.
Objective: Because of the importance of neuropathic pain and safe and effective treatment, in this study, we determined the effect of topiramate versus gabapentin in patients with neuropathic pain.
Methods: In this randomized clinical trial, 30 patients with pain attributed to neuropathy who had at least one month of neuropathic pain in one area, were randomized to receive either gabapentin, titrated from 300 mg/day to a maximum of 900 mg/day or topiramate, titrated from 50 mg/day to a maximum of 100 mg/day after a 4-week period in the neurology clinic of Imam Khomeini Hospital of Urmia city, Iran in 2015. Complication, drug tolerance rate and pain were investigated. The pain was measured on visual analog scale (VAS). The data were analyzed by SPSS version 18, and using descriptive statistics, t-test, and ANOVA.
Results: In patients treated by gabapentin, the primary pain score was 74.33±10.29, this score decreased to 49.46±11.41 and 29.93±11.92 in the second and fourth week after intervention with gabapentin. In topiramate treated patients, the primary score was 76.00±9.69. It decreased to 54.33±10.31 and 34.20±6.09 at the same time. There were no significant differences between both groups in terms of average reduction of pain intensity [gabapentin group (59.73%) compared with topiramate (55%) (p=0.48)]. In the present study, the only complication reported in patients treated by gabapentin was drowsiness, but other uncommon side effects were nausea and dizziness.
Conclusion: This study showed that both gabapentin and topiramate reduce pain. Topiramate can also be a good alternative choice, if gabapentin has side effects for patients and it cannot be tolerated, topiramate can be a good replacement.
Trial registration: The trial was registered at the Thai Registry of Clinical Trials (http://www.clinicaltrials.in.th) with the TCTR ID: TCTR20170615001.
Funding: This research has been financially supported by Research Council of Urmia University of Medical Sciences.
References
Longo DL, Kasper DL, Jameson JL, Fauci AS,Houser SL, Loscalzo J et al. Peripheral Neuropathy.
Harrison's principles of internal medicine. 18thed. New York: McGraw Hill; 2012; 384-385.
Wolfe GI, Barohn RJ. Painful Peripheral Neuropathy. Curr Treat Options Neurol. 2002; 4(3):177-88. doi:
1007/s11940-002-0034-0
Yawn BP, Wollan PC, Weingarten TN, Watson JC, Hooten WM, Melton LJ, 3rd. The prevalence of
neuropathic pain: clinical evaluation compared with screening tools in a community population. Pain Med.
; 10(3):586-93. doi: 10.1111/j.1526-4637.2009.00588.x. Epub 2009 Mar 17.
Bennett DL. Neurotrophic factors: important regulators of nociceptive function. Neuroscientist. 2001;
(1):13–7. doi: 10.1177/107385840100700105, PMid: 11486340
Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful
neuropathic disorders. J Pain. 2004; 5(3):143–9. doi: 10.1016/j.jpain.2003.12.004, PMid: 15106126
Guirguis-Blake J, Kelly C. Are opioids effective in the treatment of neuropathic pain? Am Fam Physician.
; 75(7):999-1001. PMid: 17427612
Cayley WE, Jr. Antidepressants for the treatment of neuropathic pain. Am Fam Physician. 2006;
(11):1933-4. PMid: 16770921
Otto M, Bach FW, Jensen TS, Brosen K, Sindrup SH. Escitalopram in painful polyneuropathy: a
randomized, placebo-controlled, cross-over trial. Pain. 2008; 139(2):275-83. doi:
1016/j.pain.2008.04.012. Epub 2008 Jun 10.
Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, et al. A randomized controlled
trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006;67(8):1411-20. doi:
1212/01.wnl.0000240225.04000.1a, PMid: 17060567
Grosskopf J, Mazzola J, Wan Y, Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in
painful diabetic neuropathy. Acta Neurol Scand. 2006; 114(3):177-80. doi: 10.1111/j.1600- 0404.2005.00559.x, PMid: 16911345
McCleane GJ. Comment on: Serpell et al., gabapentin in neuropathic pain syndromes: a randomised
double-blind, placebo controlled trial (Pain 2002; 99: 557-66). Pain. 2003;103(1-2):227; author reply 8.
doi: 10.1016/S0304-3959(03)00072-1
Bouhassira D, Letanoux M, Hartemann A. Chronic pain with neuropathic characteristics in diabetic
patients: a French cross-sectional study. PLoS One. 2013; 8(9):e74195. doi: 10.1371/journal.pone.0074195.
eCollection 2013.
Chong MS, Libretto SE. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain.
; 19(1):59-68. doi: 10.1097/00002508-200301000-00008
Boyd AL, Barlow PM, Pittenger GL, Simmons KF, Vinik AI. Topiramate improves neurovascular
function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus.
Diabetes Metab Syndr Obes. 2010; 3:431-7. doi: 10.2147/DMSOTT.S13699.
Dib JG. Focus on topiramate in neuropathic pain. Curr Med Res Opin.2004 Dec;20(12):1857-61. doi:
1185/030079904X11358, PMid: 15701203
Fowler JA, Shen JY, Bettinger TL. Successful Use of Topiramate in a Patient with Severe Postherpetic
Neuralgia. Ann Pharmacother 2009; 43:139-42. doi: 10.1345/aph.1L470. Epub 2008 Dec 23.
Carroll DG, Kline KM, Malnar KF. Role of topiramate for the treatment of painful diabetic peripheral
neuropathy. Pharmacotherapy: Pharmacotherapy. 2004; 24(9):1186-93. PMid: 15460179, doi:
1592/phco.24.13.1186.38096
Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J,et al. Topiramate vs placebo in
painful diabetic neuropathy: analgesic and metabolic effects.Neourology. 2004 Sep 14;63(5):865- 73. doi:
1212/01.WNL.0000137341.89781.14
Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic
neuropathy: an open-label pilot study. J Pain Symptom Manage. 2000 Oct 31; 20(4):280-5. doi:
1016/S0885-3924(00)00181-0
20.Backonja M,Beydoun A,Edwards KR,Schwartz SL,Fonseca V,Hes M,et al.Gabapentin for the
symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA. 1998;
(21):1831-1836. doi: 10.1001/jama.280.21.1831
Gilron I,Bailey JM,Tu D,Holden RR,Weaver DF,Houlden RL. Morphine, Gabapentin, or Their
Combination for Neuropathic Pain. N Engl J Med. 2005; 352:1324-34. doi: 10.1056/NEJMoa042580,
PMid: 15800228
Punam J, Omi C, Anusuya G, R. K. R, Raghuveer C, Rajesh C. A Comparative Study of the Effect of
Gabapentin, Topiramate, Levetiracetam and Zonisamide for Neuropathic Pain Induced by Anticancer Drug
(Vincristine) in Rats. JPRCP. 2014; 4(1):1-6
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
